Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CEL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,058
Award facts
- Contract value 100% obligated
- $36,057.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,057.55 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 30, 2025, issued on December 29, 2025. AmerisourceBergen Drug Corp will perform the work from its corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant commonly used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis, indicating this procurement supports military or federal healthcare system needs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to military healthcare programs worldwide, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's competitive positioning and track record of successful federal pharmaceutical procurement make it a key vendor in the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9CEL?
SPE2DR26F9CEL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9CEL worth?
The government has obligated $36,058 on SPE2DR26F9CEL.
Is contract SPE2DR26F9CEL an order under another contract?
Yes. SPE2DR26F9CEL is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CEL competed?
The extent of competition for SPE2DR26F9CEL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award